Board Certifications

American Board of Emergency Medicine
American Board of Internal Medicine

Previously Funded Research

A Prospective Multicenter Dose-Ranging Study of Intra-Arterial Thrombolysis in Acute Middle Cerebral Artery Thrombolysis in Acute Middle Cerebral Artery Distribution Thromboembolic Stroke
Funded by Abbott Laboratories, 1996

Emergency Care Services/VAMC
Funded by Veterans Administration Agency No. V152P-3288, 1995

A Randomized Trial of an Invasive Versus Noninvasive Diagnostic Strategy in Evaluation of Emergency Department Patients with Acute Chest Pain
1994

Comparison of Intravenous D-Sotalol and Placebo in the Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm
Funded by Bristol-Myers Squibb, 1994

A Multicenter, Open-Label, Ascending-Dose, Safety and Tolerability Trial to Compare the Effects of CGP-39393 and Heparin When Given in Conjunction with Recombinant Tissue-Type Plasminogen Activator (rt-PA) to Patients with Acute Transmural Myocardial Infarction
Funded by Ciba-Geigy, 1992

Tissue Plasminogen Activator in Acute Ischemic Stroke
Funded by NIH- National Institute of Neurological Diseases and Stroke, 1991

A Randomized, Double-Blind, Multicenter Study Comparing Myocardial Function, Patency, and Safety of Intravenous Eminase (anistreplase; APSAC; BRL 26921) versus Intravenous Alteplase (t-PA) in Patients with an Acute Myocardial Infarction
Funded by Beecham, 1989 – 1990

An Evaluation of the Efficacy and Safety of Intravenous Nicardipine in Comparison to Placebo in the Treatment of Severe Hypertension With or Without End Organ Damage – A Double Blind, Randomized Multicenter Study
Funded by DuPont, 1987 – 1990

An Open Label Study Comparing the Efficacy of Oral Nifedipine vs. Parenteral Labetalol in the Management of Hypertensive Urgencies
Funded by Pfizer, 1987 – 1988

Immunotherapy of Disseminated Renal Cell Carcinoma with Recombinant Human Interleukin-2 (Ro 23-6019, rIL-2): A Phase II Study
1986 – 1988

Academic Interests

Emergency Medicine
Aerospace Medicine
Chest Pain Evaluation
Emergency Cardiology